Top Markets
#1 EXOD EXOD +56.80%
#2 Glidr Glidr +35.94%
#3 Cysic Cysic +20.83%
#4 Velvet Velvet +19.00%
#5 Bedrock Bedrock +18.46%
#6 Nockchain Nockchain +16.19%
#7 Fabric Protocol Fabric Protocol +13.90%
#8 Perle Perle +12.76%
#9 Versatize Coin Versatize Coin +12.49%
#10 Starpower Starpower +12.07%
Coin of the day
EXOD EXOD
設定
言語
日本
通貨
USD
テーマ
Amniotics AB (publ) Amniotics AB (publ)

Amniotics AB (publ)

AMNI
株式のランク #37511
Amniotics AB (publ) specializes in the creation, manufacturing, and... Amniotics AB (publ) specializes in the creation, manufacturing, and commercialization of stem cell-based therapies, utilizing mesenchymal stem cells to address critical, life-threatening illnesses. The company's primary therapeutic candidate, PulmoStem, is designed for the treatment of inflammatory and fibrotic conditions affecting the lungs. Furthermore, Amniotics is advancing other promising treatments such as CogniStem for neurological disorders, NephroStem for kidney-specific ailments, and CutiStem for various dermatological issues. Beyond its own pipeline, the firm provides contract development and manufacturing services for advanced therapy medicinal products to pharmaceutical companies, universities, and hospitals. Established in 2015, Amniotics AB is headquartered in Lund, Sweden.
株価
$0.00060315
最終同期: 2024-09-27
時価総額
$1.65M
変化（1日）
19.64%
変化（1年）
0.00%
国
SE
取引 Amniotics AB (publ) (AMNI)

カテゴリー

Healthcare
Amniotics AB (publ)（AMNI）の配当利回りの履歴
Amniotics AB (publ)（銘柄コード: AMNI）の配当利回り（TTM）は2022-12-31時点で0.00%です。
過去5年間の平均配当利回り: 0.00%
Amniotics AB (publ)（AMNI）の2018から2026までの配当利回りの履歴
各年末時点の配当利回り（TTM）
年 配当利回り 変化
2026 (TTM) 0.00% 0.00%
2023 0.00% 0.00%
2022 0.00% 0.00%
2021 0.00% 0.00%
2020 0.00% 0.00%
2019 0.00% 0.00%
2018 0.00% 0.00%
類似企業または競合他社の配当利回り（TTM）
企業 配当利回り 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
0.00%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
0.48%
BE